Dr. Dinesh Kumar Dhull

Education

B. Pharmacy (Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India)

M. Pharmacy (ISF College of Pharmacy, Moga, Punjab, India)

Ph.D. (University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India)

Research Area

Neurodegeneration, Neuropsychiatry, Neuroinflammation

Patents

• METHODS AND COMPOSITIONS FOR TREATING AGITATION WO2022183029 | CA3208828 | EP4297871 | US20240139169 | CN117412747 | JP2024507991
• METHODS AND COMPOSITIONS FOR TREATING ACUTE STRESS DISORDER WO2024050028 | EP4580619
• COMBINATION OF LATREPIRDINE AND A PHARMACOKINETIC STABILIZER WO2025128666

Certificate Courses

• Online Training programme on ‘NEP Orientation & Sensitization’ under the Malaviya Mission Teacher Training Programme (MMTTP).
• NPTEL Online Certificate course on ‘Current regulatory requirements for conducting clinical trials in India for investigational new drugs_new drug’.
• NPTEL Online Certificate course on ‘Patent Drafting for Beginners’.
• Certificate course on ‘Python Programming’.
• One year certificate course on ‘Care, Breeding and Management of Laboratory Animals’ from Central Animal Research Facility, NIMHANS, Bangalore.

Participation in Institutional Programs and Initiatives

• Participated as a resource person in IBRO/APRC Neuroscience School (2016) on the theme of "Basic & Research Concepts of Neuropsychiatric Disorders" held at Panjab University, Chandigarh.
• Participated as a resource person in 2nd DST Inspire Internship Camp (2015) held at Panjab University, Chandigarh.
• Participated as a resource person in PDEP workshop (2014) on "Understanding Parkinson's disease: From clinics to basics" help at NIMHANS, Bangalore.
• Participated as a resource person in APPICON (2013) workshop on "Current physiological techniques: From basic to applied aspects" help at NIMHANS, Bangalore

Publications

• Yocca FD, Dhull DK, Seth S, Chugh M, Sharma S, Nandabalan K, Postma FR and De Vivo M Dexmedetomidine potently and reversibly regulates stress-mediated behaviors. Front. Pharmacol. 2025; 16:1589075. IF: 4.8
• Yocca F,* DeVivo M, Dhull D, Seth S. (2025, December 11). Latrepirdine (Dimebon) modulates stress-mediated behaviors in rodents [Poster presentation]. ACNP 63rd Annual Meeting, Phoenix, Arizona: Poster Abstracts P882. Neuropsychopharmacol. 49 (Suppl 1), 418–594. IF: 7.1
• Lohan S, Sharma T, Saini S, Swami R, Dhull D, Beg S, et al. QbD-steered development of mixed nanomicelles of galantamine: Demonstration of enhanced brain uptake, prolonged systemic retention and improved biopharmaceutical attributes. Int. J. Pharm. 2021;600:120482. IF: 5.2
• Gupta V, Dhull DK, Joshi J, Kaur S, Kumar A. Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms. Neurochem Int. 2019 Nov 18;132:104604. IF: 4.0
• Dhull DK, Kumar A. Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats. Inflammopharmacology. 2018 Aug;26(4):925-938. IF: 5.3
• Kumar A, Yadav M, Parle M, Dhingra S, Dhull DK. Potential drug targets and treatment of schizophrenia. Inflammopharmacology. 2017 Jun;25(3):277-292. IF: 5.3
• Mishra PS, Dhull DK, Nalini A, Vijayalakshmi K, Sathyaprabha TN, Alladi PA, et al. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J Neuroinflammation. 2016 Aug 30;13(1):212. IF: 10.1
• Kumar A, Dhull DK, Gupta V, Channana P, Singh A, Bhardwaj M, et al. Role of Glutathione-S-transferases in neurological problems. Expert Opin Ther Pat. 2016 27 (3), 299–309. IF: 5.4
• Kumar A, Dhull DK, Mishra PS. Therapeutic potential of mGluR5 targeting in Alzheimer's disease. Front Neurosci. 2015 Jun 9;9:215. IF: 3.2
• Kumar A, Ekavali, Chopra K, Mukherjee M, Pottabathini R, Dhull DK. Current knowledge and pharmacological profile of berberine: An update. Eur J Pharmacol. 2015 Jun 16. pii: S0014-2999(15)30057-1. IF: 4.7
• Kumar, Anil, et al. "Highlights of 2nd Taiwan International Congress of Parkinson's Disease and Movement Disorders, Taipei, Taiwan (March 28-29, 2015): Parkinson's Disease and Movement Disorder- an Update." International Journal of Pharmaceutics and Drug Analysis, vol. 3, no. 7, 31 Jul. 2015, pp. 246-254.
• Gandhi DN, Panchal GM, Dhull DK. Neurobehavioral toxicity in progeny of rat mothers exposed to methylmercury during gestation. Ann Ist Super Sanità 2014; 50(1):28-37. IF: 1.7
• Gandhi DN, Panchal GM, Dhull DK. Influence of gestational exposure on the effects of prenatal exposure to methyl mercury on postnatal development in rats. Cent Eur J Public Health 2013 Mar;21(1):30-5. IF: 1.1
• Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SS. Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats. J Mol Neurosci. 2012 Jan;46(1):223-35. IF: 2.7
• Dhull DK, Bhateja D, Dhull RK, Padi SS. Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain. J Chem Neuroanat. 2012 Jan;43(1):48-51. IF: 2.7
• Bhateja DK, Dhull DK, Gill A, Sidhu A, Sharma S, Reddy BV, et al. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur J Pharmacol. 2012 Jan 5;674(1):33-43. IF: 4.7